Internal Medicine Alert
RSSArticles
-
Acute STEMI or False Alarm?
-
Clinical Briefs
In this section: antiretroviral therapy in HIV patients; comparing ticagrelor against aspirin in stroke patients; and weighing the many type 2 diabetes treatments.
-
Lifitegrast Ophthalmic Solution (Xiidra)
Lifitegrast is approved for the treatment of the signs and symptoms of dry eye disease.
-
Which Patients with TIA Are at High Risk for Recurrent Cerebral Vascular Events?
The objective of this study was to determine predictors of early recurrent cerebral vascular events among patients with transient ischemic attacks or minor stroke.
-
Predictive Accuracy of the New Risk Equation
In a large real-world population, the Pooled Cohort Risk Equation substantially overestimated five-year risk of cardiovascular events in adults without diabetes.
-
Improving Blood Pressure Through Enhanced Sleep
The use of a benzodiazepine hypnotic among hypertensive patients was associated with improvements in both sleep scores and blood pressure.
-
Clinical Briefs
In this section: debunking an asthma treatment; more questions than answers with perioperative statin treatment; and another reason to stay away from cocaine.
-
Lixisenatide Injection (Adlyxin)
Lixisenatide is indicated as an adjunct to diet and exercise to improve glycemic control in adults suffering from type 2 diabetes mellitus.
-
Dual Antiplatelet Therapy Appears More Effective Than Single Therapy
It appears short-term dual antiplatelet therapy is superior to prolonged treatment, but a difference in outcome must be confirmed by further well-designed randomized, clinical trials.
-
Greater Weight Loss Later in Life Associated with Increased Risk of Mild Cognitive Impairment
In a population-based, prospective study of subjects ≥ 70 years of age, increasing weight loss per decade from midlife to late-life was associated with an increased risk of incident mild cognitive impairment.